Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. KURE
KURE logo

KURE

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

KURE News

Eli Lilly CEO Criticizes PBM 'Rent-Seeking', Claims They Increased Insulin List Prices to $275: 'We Can Easily Bypass Them'

Nov 12 2025Benzinga

Economist Warns Trump's Full Drug Tariff Will Burden Americans, Not Foreign Companies

Sep 29 2025Benzinga

Mark Cuban Reveals How Wholesalers Coerce Pharmacies into Nearly Exclusive Agreements, Highlighting PBMs' 'Stranglehold' on Medication Costs

Sep 08 2025Benzinga

Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More'

Aug 01 2025Benzinga

Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains'

Jul 16 2025Benzinga

Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies

Jul 11 2025Benzinga

Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'

Jun 20 2025Benzinga

Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion

May 19 2025Benzinga

Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies

Apr 11 2025Benzinga

Asia markets mixed as markets weigh Trump tariffs; yen weakens on soft PMI data

Mar 24 2025SeekingAlpha

Asia markets mixed after Wall Street dips as growth, tariff worries weigh

Mar 21 2025SeekingAlpha

Asia markets mixed after Fed hold; China holds LPR rate steady for 5th month

Mar 20 2025SeekingAlpha

People’s Bank of China keeps lending rates unchanged, in line with expectations

Mar 20 2025SeekingAlpha

Asia-Pacific markets muted after Wall Street falls, yen weakens as BOJ holds rates steady

Mar 19 2025SeekingAlpha

Asia markets gains, Hong Kong soars on AI hype, China stimulus cheer

Mar 18 2025SeekingAlpha

China’s consumption stimulus boosts Asia shares, Oil prices jump

Mar 17 2025SeekingAlpha